Effects of <i>ABCB1</i> polymorphisms on the transport of ponatinib into the cerebrospinal fluid in Japanese Philadelphia chromosome‐positive acute lymphoblastic leukaemia patients-Reference-Cited by-同舟云学术

Effects of ABCB1 polymorphisms on the transport of ponatinib into the cerebrospinal fluid in Japanese Philadelphia chromosome‐positive acute lymphoblastic leukaemia patients

Published:2023-01-06 Issue:5 Volume:89 Page:1695-1700
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Brit J Clinical Pharma

Author:

Fukushi Yayoi¹,Akamine Yumiko¹,Abumiya Maiko¹,Tozawa Nagi²,Yamashita Takaya²,Nara Miho²,Kameoka Yoshihiro²,Takahashi Naoto²,Miura Masatomo¹³^ORCID

Affiliation:

1. Department of Pharmacy Akita University Hospital 1‐1‐1 Hondo Akita Japan

2. Department of Hematology, Nephrology, and Rheumatology Akita University Graduate School of Medicine Akita Japan

3. Department of Pharmacokinetics Akita University Graduate School of Medicine Akita Japan

Funder

Japan Society for the Promotion of Science

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.15650

Reference31 articles.

1. Brain Accumulation of Ponatinib and Its Active Metabolite, N-Desmethyl Ponatinib, Is Limited by P-Glycoprotein (P-GP/ABCB1) and Breast Cancer Resistance Protein (BCRP/ABCG2)

2. Pharmacokinetic Assessment of Cooperative Efflux of the Multitargeted Kinase Inhibitor Ponatinib Across the Blood-Brain Barrier

3. Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A New Algorithm Integrating Molecular Response, Toxicity, and Plasma Level Measures for Ponatinib Dose Choice in Patients Affected by Chronic Myeloid Leukemia;Pharmaceutics;2024-03-11

2. Clinical pharmacokinetics and drug–drug interactions of tyrosine-kinase inhibitors in chronic myeloid leukemia: A clinical perspective;Critical Reviews in Oncology/Hematology;2024-03